Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Disclosure statements are available on the authors' profiles:
A Phase II Study of Osimertinib for Radiotherapy-Naïve CNS Metastasis From Non-Small Cell Lung Cancer: Results for the T790M Cohort of the OCEAN Study (LOGIK1603/WJOG9116L)J Thorac Oncol 2021 Aug 19;[EPub Ahead of Print], H Yamaguchi, K Wakuda, M Fukuda, H Kenmotsu, H Mukae, K Ito, K Chibana, K Inoue, S Miura, K Tanaka, N Ebi, T Suetsugu, T Harada, K Kirita, T Yokoyama, Y Nakatani, K Yoshimura, K Nakagawa, N Yamamoto, K Sugio
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.